% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Teipel:282605,
author = {Teipel, Stefan and Akmatov, Manas and Michalowsky, Bernhard
and Junghanss, Christian and Holstiege, Jakob and Bohlken,
Jens},
title = {{A}ssociation of cancer with neuropathological markers of
{A}lzheimer's disease and related dementias.},
journal = {Alzheimer's $\&$ dementia / Diagnosis, assessment $\&$
disease monitoring},
volume = {17},
number = {4},
issn = {2352-8729},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {DZNE-2025-01363},
pages = {e70222},
year = {2025},
abstract = {We assessed associations of cancer diagnoses with
neuropathology of Alzheimer's disease (AD) and related
dementias.We retrieved 2288 cases from the National
Alzheimer Coordinating Center (NACC) cohort with available
information on cancer diagnoses and neuropathological
scoring of Braak stages, Thal amyloid phases, neuritic
plaques, TDP-43 pathology, and Lewy body pathology. We used
Bayesian ordinal regression to assess associations of
prevalent or incident cancer diagnoses with global cognition
and postmortem neuropathological scores.We found extreme
evidence (Bayes factor [BF] > 2000) that both prevalent and
incident cancer diagnoses were associated with better global
cognition, strong evidence (BF = 26) for an association of a
prevalent cancer diagnosis with lower TDP-43 pathology, and
weak evidence (BF = 3.2) for an association with lower Lewy
body pathology.Our data suggest that selective survival and
biological effects may contribute to the lower risk of
dementia in people with a cancer diagnosis.A prevalent
diagnosis of cancer was associated with a lower risk of
cognitive decline in older individuals.A prevalent diagnosis
of cancer was associated with a lower risk of TDP-43
pathology and Lewy body pathology in older
individuals.Effects of cancer on TDP-43 pathology were
maintained when controlling for degree of cognitive
decline.},
keywords = {Alzheimer's disease pathology (Other) / Braak stages
(Other) / TDP‐43 pathology (Other) / protective factor
(Other)},
cin = {AG Teipel / AG Michalowsky},
ddc = {610},
cid = {I:(DE-2719)1510100 / I:(DE-2719)5000067},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41367891},
pmc = {pmc:PMC12682591},
doi = {10.1002/dad2.70222},
url = {https://pub.dzne.de/record/282605},
}